By Yves Massicotte, Ropack, Inc.
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. Blister packaging reduces costs for OTC and Rx drug manufacturing significantly. Blister packaging also offers tamper proof solutions in a highly competitive market. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations.
Following are the four factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.